GRPP (human) is a regulatory peptide derived from proglucagon processing, used to study helix-turn motifs within metabolic signaling pathways. Its sequence supports mapping of flexible and structured segments. Researchers analyze residue accessibility to identify interaction features. The molecule contributes to structural characterization of proglucagon-derived peptides.
CAT No: G16028
CAS No:1132745-52-8
Synonyms/Alias:Preproglucagon (21-50) (human), Proglucagon (1-30) (human), Glicentin-Related Polypeptide (human)
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.